John Neppl
Analyst · Barclays
Thanks, Greg, and good morning, everyone. Let's turn to the earnings highlights on Slide 5. Our reported third quarter earnings per share was $2.49 compared to $4.28 in the third quarter of 2021. Our reported results include a negative mark-to-market timing difference of $0.19 per share and a net negative impact of $0.70 per share related to onetime items. Adjusted EPS was $3.45 in the third quarter versus $3.72 in the prior year. Adjusted core segment earnings before interest and taxes or EBIT was $740 million in the quarter versus $698 million last year. The higher results were driven by our Refined and Specialty Oils segment. In total, Agribusiness results of $528 million compared to $533 million last year. In Processing, results were essentially flat with the last year as increases in North and South America were offset by lower results in Europe were a combination of a sharp rise in energy costs and increased mil imports pressured margins. Results in China were down primarily due to the impact of pandemic-related lockdowns. Merchandising results of $108 million were down slightly compared to last year as higher contributions from global grains and financial services were offset by lower results in global oils marketing. In Refined and Specialty Oils, higher results reflect strong performances in our refined oil operations in South America, Europe and North America. In Milling, higher results in North America were more than offset by lower results in South America. The decrease in corporate expenses was primarily related to the timing of performance-based compensation accruals. The decrease in Other was primarily related to lower gains on investments in Bunge Ventures. Lower results in our non-core Sugar & Bioenergy joint venture were primarily driven by the combination of lower ethanol volumes and increased costs. Net interest expense was up compared to last year due to higher interest rates partially offset by lower average debt levels. Also impacting the quarter were foreign currency borrowings in certain countries where interest rates were high. However, the incrementally higher borrowing costs were fully offset with currency hedges that are reported in gross margin. Let's turn to Slide 6, where you can see our positive EPS and EBIT trends adjusted for notable items and timing differences over the past four years along with the trailing 12 months. This performance trend demonstrates our team's ability to successfully manage through rapidly changing markets and also the strength of our global platform. As shown on Slide 7, year-to-date addressable SG&A has increased modestly year-over-year, reflecting resumption of more normal business activities such as employee travel and related expenses as well as increasing investment to strengthen our capabilities and drive growth. Slide 8 details our capital allocation of approximately $1.8 billion of adjusted funds from operations that we generated year-to-date. After allocating $184 million to sustaining CapEx, which includes maintenance, environmental, health and safety, and $8 million to preferred dividends on shares now converted to common equity, we had approximately $1.6 billion of discretionary cash flow available. Of this amount, we paid $248 million in common dividends, invested $168 million in growth and productivity CapEx and repurchased $200 million of common shares during the third quarter. This left us with approximately $1 billion of retained cash flow, which we invested in additional working capital during the year while also reducing our net debt. We will continue to maintain a disciplined and balanced approach to capital allocation. Moving to Slide 9. At quarter end, readily marketable inventories, or RMI, exceeded our net debt by approximately $2.3 billion. As commodity prices have moderated recently, the cash that has been invested in inventory has been released and deployed toward debt reduction. To provide additional understanding of how commodity price movements and other factors impact our cash flow from operations, we have posted a presentation in the Investors section on our website this morning. Should you have any questions, feel free to reach out to our IR team. Slide 10 highlights our liquidity position, which remains strong. At quarter end, approximately $6.7 billion of our committed credit facilities was unused and available. This provides us ample liquidity to manage our ongoing capital needs in this volatile commodity price environment. As shown on Slide 11, our trailing 12 months adjusted ROIC was 22.2%, 15.6 percentage points over our RMI adjusted weighted average cost of capital of 6.6%. ROIC was 15.2% or 9.2 percentage points over our weighted average cost of capital of 6%. The spread between these two metrics reflects how we use RMI in our operations as a tool to generate incremental profit. Moving to Slide 12. For the trailing 12 months, we produced discretionary cash flow of approximately $2.2 billion and a cash flow yield of 21.7%. Please turn to Slide 13 and our 2022 outlook. As Greg mentioned in his remarks, taking into account our third quarter results, the current margin environment and forward curves, we've increased our full year 2022 adjusted EPS outlook to at least $13.50 per share, a $1.50 per share increase over our previous outlook. In Agribusiness, full year results are expected to be higher than our previous outlook but down from last year as stronger results in processing are more than offset by lower expected performance in Merchandising, which had a particularly strong prior year. In Refined and Specialty Oils, full year results are expected to be up from our previous outlook and significantly higher than last year, driven by our refining operations. In Milling, full year results are expected to be in line with our previous outlook and significantly higher than last year. In Corporate and Other, results are expected to be in line with our previous outlook and last year. In non-core, full year results in our Sugar & Bioenergy joint venture are expected to be lower than our previous forecast and down slightly from last year. Additionally, the Company now estimates the following for 2022: an adjusted annual effective tax rate of 16%, net interest expense of $300 million, capital expenditures of $600 million and depreciation and amortization of $400 million. We have reduced our CapEx forecast from our previous estimate of $650 million primarily due to supply chain delays. We would expect to carry the shortfall over into 2023. With that, I'll turn things back over to Greg for some closing comments.